Matthew Stober is the President and Chief Executive Officer of Istari Oncology. Mr. Stober has more than 30 years of leadership experience at large multinational pharmaceutical organizations where he successfully led multiple strategic corporate transactions, including major acquisitions and divestures. Mr. Stober held various positions in global operations as a corporate officer where he was responsible for developing and commercializing dozens of breakthrough vaccines and biopharmaceuticals at companies including Merck, Novartis, Hospira and GSK.
Prior to joining Istari, Mr. Stober was President of Operations at Smith and Nephew. Previously, he was a corporate officer and member of the executive committee at Hospira, where he managed 12,000+ global employees and led a turnaround at the company that resulted in a $17B acquisition by Pfizer. He also held global leadership positions at Novartis, where he successfully launched three novel vaccines in four years with sales of $3B.
Mr. Stober earned a Bachelor of Science in chemical engineering from Villanova University. He currently serves on the Board of Directors for Istari Oncology and X-Vax Technology, as well as the Technical Advisory Board at Catalent Biologics and Adverum Biotechnologies.